Clinical Trial Update: Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the effectiveness of accelerated corneal crosslinking for infectious keratitis. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratitis

Drugs mentioned

• Riboflavin ophthalmic solution (riboflavin)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Keratitis | Phase 3 | Status: UNKNOWN